112 related articles for article (PubMed ID: 22858378)
1. Transglutaminase-mediated transamidation of serotonin, dopamine and noradrenaline to fibronectin: evidence for a general mechanism of monoaminylation.
Hummerich R; Thumfart JO; Findeisen P; Bartsch D; Schloss P
FEBS Lett; 2012 Sep; 586(19):3421-8. PubMed ID: 22858378
[TBL] [Abstract][Full Text] [Related]
2. Monoaminylation of Fibrinogen and Glia-Derived Proteins: Indication for Similar Mechanisms in Posttranslational Protein Modification in Blood and Brain.
Hummerich R; Costina V; Findeisen P; Schloss P
ACS Chem Neurosci; 2015 Jul; 6(7):1130-6. PubMed ID: 25794141
[TBL] [Abstract][Full Text] [Related]
3. Serotonylation and Transamidation of Other Monoamines.
Muma NA; Mi Z
ACS Chem Neurosci; 2015 Jul; 6(7):961-9. PubMed ID: 25615632
[TBL] [Abstract][Full Text] [Related]
4. Serotonin--more than a neurotransmitter: transglutaminase-mediated serotonylation of C6 glioma cells and fibronectin.
Hummerich R; Schloss P
Neurochem Int; 2010 Aug; 57(1):67-75. PubMed ID: 20451572
[TBL] [Abstract][Full Text] [Related]
5. Novel roles for biogenic monoamines: from monoamines in transglutaminase-mediated post-translational protein modification to monoaminylation deregulation diseases.
Walther DJ; Stahlberg S; Vowinckel J
FEBS J; 2011 Dec; 278(24):4740-55. PubMed ID: 21923757
[TBL] [Abstract][Full Text] [Related]
6. Role of protein transamidation in serotonin-induced proliferation and migration of pulmonary artery smooth muscle cells.
Liu Y; Wei L; Laskin DL; Fanburg BL
Am J Respir Cell Mol Biol; 2011 Apr; 44(4):548-55. PubMed ID: 20558776
[TBL] [Abstract][Full Text] [Related]
7. The physiology, pathology and potential therapeutic application of serotonylation.
Jiang SH; Wang YH; Hu LP; Wang X; Li J; Zhang XL; Zhang ZG
J Cell Sci; 2021 Jun; 134(11):. PubMed ID: 34085694
[TBL] [Abstract][Full Text] [Related]
8. Serotonin (5-HT) inhibits Factor XIII-A-mediated plasma fibronectin matrix assembly and crosslinking in osteoblast cultures via direct competition with transamidation.
Cui C; Kaartinen MT
Bone; 2015 Mar; 72():43-52. PubMed ID: 25460579
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase-catalyzed transamidation: a novel mechanism for Rac1 activation by 5-hydroxytryptamine2A receptor stimulation.
Dai Y; Dudek NL; Patel TB; Muma NA
J Pharmacol Exp Ther; 2008 Jul; 326(1):153-62. PubMed ID: 18400843
[TBL] [Abstract][Full Text] [Related]
10. Deamidation and transamidation of substance P by tissue transglutaminase revealed by electron-capture dissociation fourier transform mass spectrometry.
Fornelli L; Schmid AW; Grasso L; Vogel H; Tsybin YO
Chemistry; 2011 Jan; 17(2):486-97. PubMed ID: 21207565
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of the action of tissue transglutaminase on peptide and protein substrates.
Case A; Stein RL
Biochemistry; 2003 Aug; 42(31):9466-81. PubMed ID: 12899634
[TBL] [Abstract][Full Text] [Related]
12. GTP is required to stabilize and display transamidation activity of transglutaminase 2.
Jeon JH; Cho SY; Kim CW; Shin DM; Kweon JC; Choi KH; Park SC; Kim IG
Biochem Biophys Res Commun; 2002 Jun; 294(4):818-22. PubMed ID: 12061780
[TBL] [Abstract][Full Text] [Related]
13. Functional activation by central monoamines of human dopamine D(4) receptor polymorphic variants coupled to GIRK channels in Xenopus oocytes.
Wedemeyer C; Goutman JD; Avale ME; Franchini LF; Rubinstein M; Calvo DJ
Eur J Pharmacol; 2007 May; 562(3):165-73. PubMed ID: 17350612
[TBL] [Abstract][Full Text] [Related]
14. Monoamine modulation of tonic GABAA inhibition.
Crunelli V; Di Giovanni G
Rev Neurosci; 2014; 25(2):195-206. PubMed ID: 24468610
[TBL] [Abstract][Full Text] [Related]
15. The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP.
Iismaa SE; Chung L; Wu MJ; Teller DC; Yee VC; Graham RM
Biochemistry; 1997 Sep; 36(39):11655-64. PubMed ID: 9305955
[TBL] [Abstract][Full Text] [Related]
16. An in vivo tagging method reveals that Ras undergoes sustained activation upon transglutaminase-mediated protein serotonylation.
Lin JC; Chou CC; Gao S; Wu SC; Khoo KH; Lin CH
Chembiochem; 2013 May; 14(7):813-7. PubMed ID: 23592595
[TBL] [Abstract][Full Text] [Related]
17. Enhanced osteoblast adhesion on transglutaminase 2-crosslinked fibronectin.
Forsprecher J; Wang Z; Nelea V; Kaartinen MT
Amino Acids; 2009 Apr; 36(4):747-53. PubMed ID: 18604470
[TBL] [Abstract][Full Text] [Related]
18. Appraisal of current methods to estimate the turnover rate of serotonin and catecholamines in human brain.
Costa E
Adv Biochem Psychopharmacol; 1972; 4():171-83. PubMed ID: 4402386
[No Abstract] [Full Text] [Related]
19. Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy.
Yuan L; Siegel M; Choi K; Khosla C; Miller CR; Jackson EN; Piwnica-Worms D; Rich KM
Oncogene; 2007 Apr; 26(18):2563-73. PubMed ID: 17099729
[TBL] [Abstract][Full Text] [Related]
20. Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA.
Hoffmann BR; Annis DS; Mosher DF
J Biol Chem; 2011 Sep; 286(37):32220-30. PubMed ID: 21757696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
